Skip to content

Preventing injuries among recreational adult volleyball players

Preventing musculoskeletal injuries among recreational adult volleyball players: a randomised prospective controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22405
Enrollment
640
Registered
2017-02-01
Start date
2017-08-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal injuries, especially finger/wrist, shoulder, knee and ankle injuries

Interventions

Intervention ‘VolleyVeilig’ vs. Volleyball as usual

Sponsors

- Dutch Consumer Safety Institute, Amsterdam, the Netherlands - Academic Center for Evidence based Sports medicine (ACES), Academic Medical Center, Amsterdam, The Netherlands - Center for Sports Medicine, University of Groningen, University Medical Center Groningen, The Netherlands Amsterdam - Collaboration for Health & Safety in Sports (ACHSS), Academic Medical Center / VU University Medical Center, Amsterdam, The Netherlands - Department of Public and Occupational Health, VU University Medica
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria are: (i) 18 years of age or older; (ii) playing in a volleyball team competing recreationally in one of the two competition regions involved in the study; (iii) practicing volleyball (training and/or match) at least twice a week; (iv) speaking and reading Dutch fluently; (v) owning an email address.

Exclusion criteria

Exclusion criteria: Participants being injured at the start of the study will be excluded.

Design outcomes

Primary

MeasureTime frame
Incidence of acute injury Prevalence of overuse injury Compliance with intervention

Contacts

Public ContactVincent Gouttebarge

-Academic Center for Evidence-based Sports medicine (ACES) Academic Medical Center (AMC), Amsterdam, The Netherland - Dutch Consumer Safety Institute (VeiligheidNL), Amsterdam, The Netherlands

Email: v.gouttebarge@amc.nlTel: +31621547499

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)